thrombolyt therapi myocardi infarct assess efficaci myocardi perfus sestamibi sestamibi efficaci thrombolyt therapi imag qualiti due photon energi allow dose radiopharmaceut along lack redistribut sestamibi accept imag agent studi imag agent serial quantit planar tomograph imag initi risk area infarct chang time relat infarct-rel arteri patenc patient first acut myocardi infarct patient recombin tissue-typ plasminogen activ rt-pa hour onset acut chest pain patient convent manner thrombolyt therapi initi area risk patient rt-pa convent therapi patient success thrombolysi patient infarct arteri reduct sestamibi defect size patient persist coronari occlus serial sestamibi import applic futur clinic research efficaci new thrombolyt agent direct measur amount hypoperfus myocardium thrombolysi rapid unequivoc result patient use mortal end point approach clinic arena 